DeepIntent has named Ian Colley—most recently CMO of The Trade Desk—as its new chief marketing officer, effective late April.
Colley joins as the healthcare-focused demand-side platform (DSP) as the Trump administration weighs restrictions on pharmaceutical advertising that could disrupt more than $10 billion in annual ad spending.
At DeepIntent, Colley will oversee marketing and communications and will report to the company’s founder and CEO, Chris Paquette. He succeeds Adam Kapel, who left the company in 2024.
Colley brings more than three decades of marketing and communications experience to the role, including seven years at The Trade Desk and earlier stints at IBM.
